2024 surveillance of non-alcoholic fatty liver disease (NAFLD): assessment and management (NICE guideline NG49)
Prioritisation Board recognised that there is a significant amount of new evidence in this area and agreed that there is a clear system need for up-to-date guidance on this topic.
Review decision: Prioritised
We have checked the evidence and plan to update this guideline.
This page was last updated: